Drug or treatment

Axitinib clinical trials

• 14Clinical trials
• 4Countries

Newest trials

All recruiting trials (14)

• SABR with Axitinib and Toripalimab for oligometastatic kidney cancer

  This phase 2 trial tests whether giving SABR radiation together with axitinib and toripalimab can shrink tumors and help patients with up to five metastatic sites from clear cell renal cell carcinoma.

  Recruiting Phase 2 Hebei Medical University Fourth Hospital · Shijiazhuang, Hebei · NCT07744932

• Long-term safety test of the Axitinib implant for people with neovascular AMD who finished prior OTX-TKI studies

  This study checks long-term safety of the Axitinib intravitreal implant in people with neovascular AMD who completed prior OTX-TKI studies.

  Recruiting at 8 sites Phase 3 Ocular Therapeutix, Inc. · Bakersfield, California and 7 other locations · NCT07516132

• SLC-3010 plus axitinib versus axitinib alone for second-line treatment of advanced clear cell kidney cancer

  This trial tests whether adding SLC-3010 to axitinib works better than axitinib alone for adults with locally advanced or metastatic clear cell kidney cancer who need second-line treatment.

  Recruiting Phase 2 Yonsei University · Seoul · NCT07469683

• OTX-TKI (axitinib intravitreal implant) for non-proliferative diabetic retinopathy

  This trial will test whether a long-acting axitinib hydrogel implant injected into one eye can slow worsening in adults with moderately severe to severe non-proliferative diabetic retinopathy.

  Recruiting Phase 3 Ocular Therapeutix, Inc. · Hagerstown, Maryland · NCT07235085

• Pre-surgery targeted artery embolization plus toripalimab and axitinib for advanced kidney cancer

  This test tries a targeted artery embolization one week before starting toripalimab plus axitinib to shrink advanced kidney tumors and improve outcomes for people preparing for surgery.

  Recruiting Phase 2 Tianjin Medical University Second Hospital · Tianjin, Tianjin Municipality · NCT07172386

• Combining sasanlimab, palbociclib, and axitinib for metastatic kidney cancer

  This test tries a combination of sasanlimab, palbociclib, and axitinib in people with advanced or metastatic clear cell or translocation renal cell carcinoma to see if it works and is safe.

  Recruiting at 2 sites Phase 2 Dana-Farber Cancer Institute · Boston, Massachusetts and 1 other locations · NCT07123090

• Combining radiation therapy with targeted and immunotherapy for advanced kidney cancer

  This study is testing a new treatment that combines radiation therapy with two other medications to see if it helps people with advanced kidney cancer live longer without their disease getting worse.

  Recruiting Phase 2 Peking University First Hospital · Beijing, Beijing Municipality · NCT06889649

• Evaluating immunotherapy with axitinib for advanced collecting duct carcinoma

  This study is testing a new combination of immunotherapy and axitinib to see if it can help people with advanced collecting duct carcinoma who have already tried other treatments.

  Recruiting Phase 2 Peking University Cancer Hospital & Institute · Beijing, Beijing Municipality and 1 other locations · NCT06211114

• Combining Pembrolizumab and Axitinib for Kidney Cancer with Tumor Thrombus

  This study is testing whether combining two medications, Pembrolizumab and Axitinib, can help shrink kidney cancer tumors that have spread to a major vein before surgery.

  Recruiting at 3 sites Phase 2 University of Colorado, Denver · Aurora, Colorado and 2 other locations · NCT05969496

• Combining axitinib with nivolumab for advanced kidney cancer treatment

  This study is testing if adding a drug called axitinib to nivolumab can help people with advanced kidney cancer see better results than just using nivolumab alone.

  Recruiting Phase 2 Consorzio Oncotech · Brescia and 22 other locations · NCT05817903

• Postoperative treatment for high-risk non-clear renal cell carcinoma

  This study is testing if a combination of two medications can help prevent the return of non-clear renal cell carcinoma in patients who have just had surgery to remove their tumor.

  Recruiting at 2 sites Phase 2 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Nanjing, Jiangsu and 1 other locations · NCT05768464

• Combining Axitinib and PD-1 to Improve Outcomes in Kidney Cancer

  This study is testing if a combination of axitinib and PD-1 therapy can help kidney cancer patients who are at high risk of their cancer coming back after surgery.

  Recruiting at 8 sites Phase 3 Sun Yat-sen University · Beijing and 7 other locations · NCT05738694

• Combining axitinib and nivolumab for treating advanced mucosal melanoma

  This study is testing if a new combination of two cancer drugs, axitinib and nivolumab, can help people with advanced mucosal melanoma who haven't had treatment before feel better and live longer.

  Recruiting at 2 sites Phase 2 Memorial Sloan Kettering Cancer Center · Harrison, New York and 1 other locations · NCT05384496

• Combining talazoparib with palbociclib, axitinib, or crizotinib for advanced solid tumors

  This study is testing a new combination of drugs for people with advanced solid tumors to see which mix works best and is safest to use.

  Recruiting Phase 1 M.D. Anderson Cancer Center · Houston, Texas · NCT04693468

Quick answers

How many clinical trials of Axitinib are recruiting right now?

14, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in China (6 trials), United States (6 trials), South Korea (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 10, Phase 3: 3, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →